In vivo cytokine and neuroendocrine responses to endotoxin in human immunodeficiency virus-infected subjects

Journal of Infectious Diseases

Volumn 180, Issue 1, 1999, Pages 106-115

  Da Silva, Barbara ^a   Singer, William ^a   Fong, Ignatius W ^a   Ottaway, Clifford A ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CYTOKINE; ENDOTOXIN; HYDROCORTISONE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NEUROENDOCRINOLOGY; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL;

ADRENOCORTICOTROPIC HORMONE; ADULT; CYTOKINES; FEMALE; HIV INFECTIONS; HUMANS; HYDROCORTISONE; INTERLEUKINS; LIPOPOLYSACCHARIDES; MALE; MODELS, BIOLOGICAL; NEUROSECRETORY SYSTEMS; NOREPINEPHRINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032977715     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314819     Document Type: Article

References (46)

1. Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature 1996;384:529-34.
2. Pantaleo G, Fauci AS. New concepts in the immunopathogenesis of HIV infection. Annu Rev Immunol 1995;13:487-512.
3. Parillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 1993;328:1471-7.
4. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune mediated inflammation. N Engl J Med 1995;332:1351-62.
5. Martich GD, Boujoukos AJ, Suffredini AF. Response of man to endotoxin. Immunobiology 1993;187:403-16.
6. Burrell R. Human responses to bacterial endotoxin. Circ Shock 1994;43:137-53.
7. Kuhns DB, Alvord WG, Galin JI. Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans. J Infect Dis 1995;171:145-52.
8. Beutler B, Cerami A. The biology of cachectin/TNF a primary mediator of the host response. Annu Rev Immunol 1989;7:625-55.
9. Martich GD, Danner RL, Ceska M, Suffredini AF. Detection of interleukin-8 and tumor necrosis factor in normal humans after intravenous endotoxins: the effort of antiinflammatory against. J Exp Med 1991;173:1021-4.
10. Spinas GA, Keller U, Brockhaus M. Release of soluble receptors for tumor necrosis factor in relation to circulating TNF during experimental endotoxemia. J Clin Invest 1992;90:533-6.
11. Fong Y, Moldawer LL, Marano M, et al. Endotoxemia elicits increased circulating β-IFN/IL-6 in man. J Immunol 1989;142:2321-4.
12. Fischer E, Van Zee KJ, Marano M, et al. Interleukin-1 receptor antagonist circulates in experimental inflammation and human disease. Blood 1992;79:2196-200.
13. Tilders F, DeRijk R, Van Dam AM, Vincent V, Schotanus K, Persoons JHA. Activation of the hypothalamic-pituitary-adrenal-axis by bacterial endotoxins: routes and intermediate signals. Psychoneuroendocrinology 1994;19:209-32.
14. Lees S, Tsou AP, Chan H, et al. Glucocorticoids selectively inhibit the transcription of the interleukin 1β gene and decrease the stability of interleukin 1β mRNA. Proc Natl Acad Sci USA 1988;85:1204-8.
15. Zanker B, Walz G, Weider K, Strom T. Evidence that glucocorticoids block expression of the human interleukin-6 gene by accessory cells. Transplantation 1990;49:183-5.
16. Zitnick R, Whiting N, Elias J. Glucocorticoid inhibition of interleukin-1 induced interleukin-6 production by human lung fibroblasts: evidence for transcriptional and post-transcriptional regulatory mechanisms. Am J Respir Cell Mol Biol 1994;10:643-50.
17. Cronstein B, Kimmel SC, Levin RI, Martinak F, Weissmann G. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule-1 and intracellular adhesion molecule-1. Proc Natl Acad Sci USA 1992;89:9991-5.
18. Severn A, Rapson NT, Hunter CA, Liew FY. Regulation of tumor necrosis factor production by adrenaline and β-adrenergic agonists. J Immunol 1992;148:3441-5.
19. Spengler RN, Chensue S, Giacherio D, Blenk N, Kunkel SL. Endogenous norepinephrine regulates tumor necrosis factor-α production macrophages in vitro. J Immunol 1994;152:3024-31.
20. van der Poll T, Coyle SM, Barbosa K, Braxton C, Lowry SF. Epinephrine inhibits tumor necrosis factor-α and potentiates interleukin 10 production during human endotoxemia. J Clin Invest 1996;97:713-9.
21. Fiorentino D, Zlotnik A, Mosman T, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991;147:3815-22.
22. de Waal Malefyt R, Abranms J, Bennett B, Figdor CG, de Vries JE. Interleukins-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
23. Bogdan C, Vodovitz Y, Nathan C. Macrophage deactivation by interleukin-10. J Exp Med 1991;174:1549-55.
24. Platzer C, Meisel C, Vogt K, Platzer M, Volk HD. Up-regulation of monocytic IL-10 by tumor necrosis factor-α and cAMP elevating drugs. Int Immunol 1995;7:517-23.
25. Wandiworanum C, Strober W. Predominant role of tumor necrosis factor-α in human monocyte IL-10 synthesis. J Immunol 1993;151:6853-61.
26. Standiford TJ, Streiter R, Lukaes N, Kunkel SL. Neutralization of IL-10 increases lethality in endotoxemia: cooperative effects of macrophage ininflammatory protein-2 and tumor necrosis factor. J Immunol 1995;155:2222-9.
27. van der Poll T, Jansen PM, Montegut W. Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia. J Immunol 1997;158:1971-5.
28. Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med 1996;334:1717-25.
29. van Zee KJ, Kohno T, Fuscher E, Rock C, Moldawer L, Lowry SF. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor-α in vitro and in vivo. Proc Natl Acad Sci USA 1992;89:4845-9.
30. van der Poll T, Lowry S. Tumor necrosis factor in sepsis; mediator of multiple organ failure or essential part in host defense? Shock 1995;3:1-12.
31. Dinarello C. Interleukin-1 and antagonism. Blood 1991;77:1627-52.
32. Ankrust P, Liabakk N, Mueller N, Lien E, Espevik T, Froeland S. Serum levels of tumor necrosis factor (TNF)-α and soluble TNF receptors in human immunodeficiency virus type 1 infection correlation to clinical, immunologic, and virologic parameters. J Infect Dis 1994;169:420-4.
33. Kalinkovich A, Englemann H, Harpaz N, Burstein R, Barak V, Kalickman I. Elevated serum levels of soluble tumor necrosis factor receptors (sTNF-R) in patients with HIV infection. Clin Exp Immunol 1992;89:351-5.
34. Christeff N, Gharakhanian S, Thobie N, Rozenbaum W, Nunez E. Evidence for changes in adrenal and testicular steroids during HIV infection. J Acquir Immune Defic Syndr 1992;5:841-7.
35. Lowisniewski T, Hilton C, Morse E, Svec F. The relationship to serum DHEA-S and cortisol levels to measure of immune function in human immunodeficiency virus related disease. Am J Med Sci 1993;305:79-85.
36. Grinspoon SK, Bilezikian KP. HIV disease and the endocrine system. N Engl J Med 1992;327:1360-5.
37. Clerici M, Belvilacqua M, Villa M, Shearer G. An immuno-endocrinological hypothesis of HIV infection. Lancet 1994;343:1552-3.
38. Hochstein HD, Fitzgerald EA, McMahon F, Varges R. Properties of US standard endotoxin (EC5) in human male volunteers. J Endotoxin Res 1994;1:52-6.
39. Mulder JW, Jos Frissen PH, Krinjnen P, et al. Dehydroepiandrosterone as a predictor for progression to AIDS in asymptomatic human immunodeficiency virus infected men. J Infect Dis 1992;165:413-8.
40. Masharoni U, Schambelan M. The endocrine complications of acquired immunodeficiency syndrome. Adv Intern Med 1993;38:323-36.
41. Hofbauer L, Heufelder A. Endocrine implications of human immunodeficiency virus infection. Medicine 1996;75:262-78.
42. Graziosi C, Pantaleo G, Fauci AS. Comparative analysis of constitutive cytokine expression in peripheral blood and lymph nodes of HIV-infected individuals. Res Immunol 1994;145:602-5.
43. Emilie Fior R, Crevon M, Boue F, Galauand P. Cytokines from lymphoid organs of HIV-infected patients: production and role in the immune disequilibrium of the disease. Res Immunol 1994;145:595-602.
44. Clerici M, Wynn T, Berzofsky J, et al. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with human immunodeficiency virus. J Clin Invest 1994;93:768-75.
45. Clerici M, Shearer G. A Th1-Th2 switch is a critical step in the etiology of HIV infection. J Immunol Today 1993;14:107-11.
46. Klein S, Dobmeyer J, Dobmeyer T, et al. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on a single cell level by flow cytometry. AIDS 1997;11:1111-8.